Here, we describe a KRS patient carrying a novel homozygous variant in ATP13A2, which was demonstrated to cause a complete loss of protein activity, in accordance with previously characterized ATP13A2 KRS-causing variants [3, 5, 9–13]. This evidence concerns the gene ATP13A2 and Kufor-Rakeb syndrome.